A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cognitive Studies |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 60 - Any |
| Updated: | 11/4/2018 |
| Start Date: | August 2010 |
| End Date: | December 2020 |
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial
in 25,875 U.S. men and women investigating whether taking daily dietary supplements of
vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of
developing cancer, heart disease, and stroke in people who do not have a prior history of
these illnesses. This ancillary study is being conducted among participants in VITAL and will
examine whether vitamin D or fish oil is associated with cognitive decline in 3000 older
participants of VITAL.
in 25,875 U.S. men and women investigating whether taking daily dietary supplements of
vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of
developing cancer, heart disease, and stroke in people who do not have a prior history of
these illnesses. This ancillary study is being conducted among participants in VITAL and will
examine whether vitamin D or fish oil is associated with cognitive decline in 3000 older
participants of VITAL.
Participants in VITAL (NCT 01169259) who meet the following criteria are eligible to
participate in this ancillary study:
1. are aged 60 or more
2. have no hearing impairment
3. indicate a willingness on the run-in phase to participate in a cognitive sub-study.
We found this trial at
1
site
Click here to add this to my saved trials
